Click here to view the Humana Medical Policy Updates Updates » September 2024 Humana Medical…
Health Care Service Corporation March 2018 Pending Medical Policy Updates
Click here to view the Health Care Service Corporation Pending Medical Policy Updates »
March 2018 Pending Medical Policies:
- Biochemical Markers of Alzheimer Disease (AD)
- Bone Turnover Markers for Diagnosis and Management of Osteoporosis and Diseases Associated with High Bone Turnover
- Cervicography and Speculoscopy
- Clinical Trial Treatment or Therapy
- Clostridial Collagenase for Fibroproliferative Disorders
- Dermatologic Applications of Photodynamic Therapy (PDT)
- Device Therapies for Gastroesophageal Reflux Disease (GERD)
- Direct Brain Infusion – Convection-Enhanced Delivery of Therapeutic Agents
- Drug Testing In Pain Management and Substance Use Disorder Monitoring
- Esophageal pH Monitoring
- Eteplirsen (Exondys 51)
- Fecal Microbiota Transplantation (FMT)
- Gait Analysis
- Hematopoietic Stem-Cell (HSC) Transplantation (HSCT) or Additional Infusion Following Preparative Regimens (General Donor and Recipient Information)
- Hematopoietic Stem-Cell Transplantation for Acute Myelogenous Leukemia (AML)
- Hematopoietic Stem-Cell Transplantation for Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL)
- Hematopoietic Stem-Cell Transplantation for Non-Hodgkin Lymphomas
- Hematopoietic Stem-Cell Transplantation for Plasma Cell Dyscrasias, Including Multiple Myeloma (MM) and POEMS Syndrome
- Image Guidance Surgery (IGS) System
- Intracranial Stenting or Angioplasty, including Endovascular Procedures
- Intravenous Anesthetics for the Treatment of Chronic Pain
- Intravenous Antibiotic Therapy and Associated Diagnostic Testing for Lyme Disease
- Laser Treatment of Congenital Port Wine Stain (PWS), Hemangiomas, and Other External Vascular Malformations
- Measurement of Phospholipase A2 in the Assessment of Cardiovascular Risk
- Measurement of Serum Antibodies to Infliximab and Adalimumab
- Minimally Invasive Coronary Artery Bypass Graft Surgery
- Organ and Tissue Transplantation (General Donor and Recipient Information)
- Plethysmography
- Prolotherapy
- Radiofrequency Ablation (RFA) of Primary or Metastatic Liver Tumors
- Thermography
- Tilt Table Testing
- Viscosupplementation for Osteoarthritis
- Wireless Capsule Endoscopy (WCE)
Policy Alerts monitors Commercial and Medicare medical policies for changes. While Payers typically update medical policies annually, there are many reasons why a Payer might review or update a policy. When reviews occur out of cycle, they may go unnoticed. Policy Alerts keeps you informed of upcoming and unexpected coverage changes affecting your product. Quickly understanding the changes Payers make can help you adjust reimbursement strategies impacting your business.
Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on Payer decisions in real-time. Whenever changes occur, email notifications containing a summary of those changes are delivered to your inbox. Clients can access detailed coverage reports and medical policies on the interactive Dashboard portal. Save time and keep focused on the important Payer medical policy reviews and coverage decisions affecting your product!
Policy Alerts takes a client-focused hands-on approach and works hard to provide our customers with helpful insights and actionable analytics over raw data. We understand what our clients need and we are dedicated to making sure we provide timely, accurate and always up-to-date reports that can be used to implement and support a successful reimbursement strategy.
Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.
Related Posts
